Simian virus 40 (SV40) is a DNA tumor virus known to induce cancers in laboratory animals. There are numerous reports of the detection of SV40 DNA and/or proteins in human malignancies of the same types as those induced by SV40 in animals, including brain cancers. However, known exposure to the virus has not yet been linked directly to cancer development in a specific individual. Here we describe the detection of SV40 sequences in the meningioma of a laboratory researcher who had a probable direct exposure to SV40 and subsequently developed a tumor positive for viral DNA sequences indistinguishable from those of the laboratory source. This case suggests a link between viral exposure and tumor development.
Simian virus 40 (SV40) was a contaminant of some early polio vaccines administered to millions of people between 1955 and 1963 Arrington and Butel, 2001; Jasani et al., 2001; Gazdar et al., 2002) . SV40 has been associated with human brain cancers since the 1970s Arrington and Butel, 2001; Jasani et al., 2001; Gazdar et al., 2002) , and a recent meta-analysis showed this association to be significant . Infectious SV40 has been recovered from two human brain tumors a decade apart by investigators in Germany and the US (Krieg and Scherer, 1984; Lednicky et al., 1995) . SV40 can induce brain tumors in hamsters and transgenic mice (Eddy et al., 1962; Gerber and Kirschstein, 1962; Brinster et al., 1984; Pinkert et al., 1987) . The virus has been shown to replicate efficiently in human fetal brain cells (O'Neill et al., 1992; Tavis et al., 1994) , to be produced by some transformed human brain cell lines (Krieg and Scherer, 1984) , and to transform human brain cells in culture (Shein, 1967) . However, one criterion to prove the viral causality of a human cancer, that virus infection should pre-date development of the tumor (Evans and Mueller, 1990; Butel, 2000) , has yet to be demonstrated directly for SV40. We report here a human brain tumor case that nearly fulfills this requirement.
The patient was a 42-year-old white female diagnosed with a meningioma (5.5 cm diameter) (Figure 1 ). The tumor, estimated by the large size to have been growing for at least 10 years, was surgically removed in June 1999 and the patient remains healthy today. The patient reported receiving oral polio vaccine in 1964, when the vaccine would have been free from SV40 contamination. In the 1980s, the patient worked in a laboratory setting using an SV40-transformed human fibroblast cell line, GM639. The experimental procedures routinely carried out by the researcher over a period of 4 years involved the open sonication of these cells for the preparation of purified plasma membranes, inadvertently producing a possible source of exposure in the form of viruscontaining aerosolized cell debris. In addition, large numbers of these transformed cells were concentrated and homogenized for the preparation of cytoplasmic extracts, providing another means of laboratory exposure to virus-containing cell debris. The GM639 cells were reported to contain episomal SV40 genomes in 1980, but no tests for virus production by the cells were described (Hwang and Kucherlapati, 1980) . Importantly, SV40 DNA is infectious. More recent reports failed to detect episomal genomes in derivatives of this cell line (Gish and Botchan, 1987; Huang et al., 1999) . However, as cultured cells evolve during passage, it is plausible that the cells produced virus earlier in their history, but lost the ability to maintain episomal SV40 upon repeated passage. Other SV40-transformed human cell lines have been virus-producers (O'Neill and Carroll, 1981; Huang et al., 1999; Bocchetta et al., 2000) .
The patient's meningioma and the GM639 transformed cell line from her former laboratory were tested by polymerase chain reaction (PCR) using primers RA1/ RA2 and RA3/RA4 against the viral regulatory region. Two products, the size of simple and complex SV40 regulatory regions (Lednicky and Butel, 2001) , were produced from the tumor sample (Figure 2a) . A single product, the size of a simple regulatory region, was produced from the cell line (Figure 2b ). Sequence analysis of the smaller product from the tumor and the amplicon from the cell line showed that the two were identical in sequence (Figure 2c ). The sequence was SV40-specific and contained a simple enhancer region. A polymorphism at nucleotide 5209 in the ori region (numbering based on SV40-776) divides the known SV40 strains into two groups (Lednicky and Butel, 2001 ). Both the tumor-associated sequence and the transformed cell line sequence shared a 'T' at this position. Sequencing of the larger product confirmed that a complex form of the regulatory region was also present in the primary tumor.
Only a simple viral regulatory region was detected in the cell line, whereas both a simple version and a regulatory region variant were observed in the tumor specimen. Natural SV40 strains isolated from monkeys are predominantly those with a simple enhancer (Ilyinskii et al., 1992; Lednicky et al., 1998; Newman et al., 1998) . However, mixtures of genomes with simple and complex regulatory regions were recovered from the brains of immunocompromised monkeys and were detected in pediatric renal transplants , suggesting that regulatory region rearrangements may be generated during viral replication in the host. Early low-passage uncloned stocks of two strains of SV40, VA45-54 and Baylor, were demonstrated previously to contain mixtures of viruses with simple and complex enhancer regions, whereas later-passage stocks contained only virus with duplications in the enhancer . It is believed that the faster-growing viruses containing duplications in the enhancer outgrew the viruses with a simple enhancer as each isolate was passed in tissue culture. We speculate that the GM639 human fibroblasts were transformed with a virus stock that contained viral genomes having a simple enhancer structure (the virus preparation used to generate the cell line in the 1970s was not reported). We interpret the mixed regulatory region types found in the brain tumor as suggestive of viral genome rearrangement within the patient. There is also the possibility that a small proportion of genomes with a complex regulatory region were present in the transformed cells and that virus with this arrangement had a selective advantage in the human host. We do not know whether the viral sequences were episomal or integrated at the time of advanced meningioma growth and surgical removal nor the cell types positive, as only limited amounts of paraffin-embedded tumor specimens were available for analysis.
Next, SV40 T-antigen gene sequences were analysed. Primers directed at the N-terminus of the gene (SVfor3, SVrev) ) generated products (105 bp) from both the tumor and the transformed cells. Sequencing confirmed that the products were SV40-specific, but this region is not informative for strain identification because it is conserved among all SV40 isolates. Products were also produced from the C-terminus of the T-antigen gene using primers TA1 and TA2 . Sequences of this T-antigen variable domain are used to distinguish SV40 strains . Sequence analysis proved the PCR product from the brain tumor to be an exact match with that from the transformed cell line (Figure 3) . Comparison of the tumor-associated T-antigen C-terminal sequence with those of known strains of SV40 revealed a match with SVCPC (GenBank number AF156108) and SVMEN, independent SV40 isolates from human brain tumors (Krieg and Scherer, 1984; Lednicky et al., 1995; Stewart et al., 1998) . The sequence also matched that of strain 777, originally isolated from an inactivated polio vaccine (Gerber and Kirschstein, 1962) and sequenced recently by J. Lednicky (GenBank accession numbers AF332562 (archetypal regulatory region) and AF332699 (complex)) (personal communication). We conclude that cell line GM639 was transformed by SV40 isolate 777.
A small amount of cerebral spinal fluid (CSF) was obtained from the patient when a surgical procedure was performed to remove a ventricular-peritoneal shunt 15 months postoperatively. VP1-specific primers directed toward a viral genomic late region near the junction with the C-terminus of the T-antigen gene produced a PCR product that gave a faint gel band when analysed. The primers generated similar-sized products from the brain tumor and the transformed cells. Sequence analysis confirmed that all the three sources yielded an identical SV40 product ( Figure 4 ). T-antigen primers failed to produce a detectable PCR product from the CSF in a single assay, and there was not adequate sample to repeat the assay.
The VP1 sequence is conserved and not diagnostic of specific viral strains. However, the result obtained indicates that a small amount of viral DNA was present in the CSF of the patient. The source of that DNA (free DNA, virus particles, or virus-positive cells) is not known. Blood and urine from the patient, obtained 2 years postoperatively, were negative for viral sequences by Board approval. Paraffin-embedded meningioma biopsy and surgical specimens were obtained. DNAs were extracted as described Arrington et al., 2000; Vilchez et al., 2002; Ling et al., 2003) in a BL3 facility free from viruses and plasmids. Normal human brain from an unrelated case was used as a negative tissue control. A sample of the GM639 cell line from the patient's former laboratory was obtained for analysis. Viral studies on the meningioma were completed before the transformed fibroblasts were received in our laboratory. DNAs were shown to be suitable for PCR using primers AG1 and AG2, which amplify the human A gammahemoglobin gene (Arrington et al., 2000) . For PCR detection of SV40 sequences, high stringency conditions were used with each set of primers for a total of 35-60 cycles, as DNA recovered from fixed tissues is frequently fragmented and of poor quality (Griffiths et al., 1998; Arrington and Butel, 2001) . PCR results were confirmed on duplicate tumor extractions performed at different times. (a) PCR amplicons, the sizes of simple (242 bp) and complex (314 bp) regulatory regions (Lednicky and Butel, 2001 ) (arrows), were produced from the brain tumor sample using primers RA1/RA2. Lanes marked ' þ ' are SV40 plasmid controls containing simple or complex regulatory regions. These plasmids contain an engineered restriction site that distinguishes them from natural isolates . Lanes marked 'À' are water controls lacking template DNA. (b) PCR products the size of a simple regulatory region (arrow) were generated from the GM639 transformed cells. Control lanes are the same as in panel a. (c) Sequence analysis of the smaller regulatory region products showed an exact match between the patient tumor and the transformed cells. Nucleotide 5209 displays polymorphisms (Lednicky and Butel, 2001 ); viral sequences from both the brain tumor and the transformed cell line contained a T at this position (marked with asterisks) SV40-positive human brain tumor AS Arrington et al PCR. No SV40-neutralizing antibodies or T-antigen antibodies were detected in her serum using a plaquereduction assay and an indirect immunofluorescence test (Butel and Ozbun, 1994) , respectively. This is the first reported link between probable laboratory exposure to SV40 prior to the development of a primary brain tumor documented to contain SV40 viral sequences identical to that of the exposure source. This case study specifically implicates SV40 in the etiology of a human central nervous system neoplasm and nearly fulfills the requirement of known viral exposure prior to cancer development to prove causality. However, there are a few limitations to the study.
The virus detected in the tumor and transformed cells was genotyped as 777/SVCPC. SVCPC has been isolated in the past on two separate occasions from primary human brain cancers, once from an adult meningioma (Krieg and Scherer, 1984) and once from a pediatric choroid plexus carcinoma (Lednicky et al., 1995) . This indicates that SVCPC has produced other human infections, notably in patients who developed central nervous system neoplasms; so it is conceivable that the patient acquired an SV40 infection from an unknown source. The repeated detection of SVCPC in brain tumors raises the question of whether this strain of SV40 is particularly neurotropic. We do not know the general prevalence of SV40 infections in humans, nor the particular prevalence of SVCPC infections, although prevalence is thought to be low. It would seem an extraordinary coincidence for the patient to have encountered both a natural infection with strain SVCPC and a laboratory exposure to strain 777, but that possibility cannot be eliminated.
We can only speculate on how the virus may have entered the patient's brain. The patient reported having a chronic sinus condition that required surgery 2 years prior to the diagnosis and removal of the tumor. Inflammation and damage due to chronic sinusitis may have allowed direct entry into the brain of virus particles or debris containing viral DNA following inhalation of aerosols generated by laboratory work. Alternatively, inflammatory cells in the patient's sinuses may have been infected by such exposure and then trafficked into the brain. SV40 DNA sequences have been detected in peripheral blood mononuclear cells from humans, suggesting lymphocyte trafficking of the virus in infected patients (David et al., 2001; Li et al., 2002; Martini et al., 2002) . Similarly, SV40 DNA was detected in peripheral blood cells of infected monkeys . If the virus directly entered the brain and underwent limited replication, this would explain the absence of detectable levels of long-lasting neutralizing antibody in the patient.
We believe this case provides strong suggestive evidence of direct exposure to a laboratory source of SV40 prior to the development of a brain tumor containing identical viral sequences. However, unknown sources of exposure to the same strain of SV40 cannot be absolutely ruled out. Investigators should seek other examples of cancer patients who had documented prior exposure to SV40, to complement this case regarding SV40 causality of human cancer. 
